Barclays Lowers Exact Sciences (NASDAQ:EXAS) Price Target to $55.00
Exact Sciences (NASDAQ:EXAS – Get Free Report) had its target price cut by equities research analysts at Barclays from $65.00 to $55.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage currently has an “overweight” rating on the medical research company’s stock. Barclays‘s price target indicates a potential upside of 23.73% from […]
Exact Sciences (NASDAQ:EXAS – Get Free Report) had its target price cut by equities research analysts at Barclays from $65.00 to $55.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage currently has an “overweight” rating on the medical research company’s stock. Barclays‘s price target indicates a potential upside of 23.73% from […]
